Latest
03.11.2024
Cellworks Personalized Therapy Biosimulation Study Produces Superior OS and DFS Predictions for Gastroesophageal Cancer Patients
Read Article
02.28.2024
CalciMedica Announces Presentation of a Preclinical Study of Auxora in Acute Kidney Injury at the AKI & CRRT Conference
Read Article
02.13.2024
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for Treatment of Severe Acute Kidney Injury
Read Article
06.05.2023
Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Car
Read Article
05.18.2023
OncoResponse Awarded $13 Million in Funding from CPRIT to Advance Cancer Immunotherapy
Read Article
01.09.2023
Coherus Agrees to Acquire Exclusive U.S. Commercial Rights to Eylea® Biosimilar FYB203 from Klinge Biopharma
Read Article